![Thomas Jensen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Jensen
Gründer bei ALLARITY THERAPEUTICS, INC.
Vermögen: 2 $ am 31.05.2024
Aktive Positionen von Thomas Jensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLARITY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.07.2022 | - |
Vorstandsvorsitzender | 08.12.2023 | - | |
Gründer | 06.04.2021 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.06.2020 | 08.12.2023 | |
Investor Relations Kontakt | 01.06.2020 | 08.12.2023 | |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Direktor/Vorstandsmitglied | 01.07.2022 | - |
Vorstandsvorsitzender | 08.12.2023 | - | |
Gründer | 01.01.2004 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 08.12.2023 |
Karriereverlauf von Thomas Jensen
Ehemalige bekannte Positionen von Thomas Jensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medical Prognosis Institute A/S
![]() Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Gründer | 01.01.2006 | - |
XRGenomics Ltd. | Gründer | 01.09.2012 | - |
Oncology Venture Sweden AB
![]() Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Thomas Jensen
Technical University of Denmark | Undergraduate Degree |
Statistik
International
Dänemark | 5 |
Vereinigtes Königreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALLARITY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Medical Prognosis Institute A/S
![]() Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Health Technology |
Oncology Venture Sweden AB
![]() Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
XRGenomics Ltd. | |
Allarity Therapeutics A/S
![]() Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Börse
- Insiders
- Thomas Jensen
- Erfahrung